IR
Superintel
Overview
Markets
Watchlist
More
Vistagen Therapeutics Inc
CUSIP: 92840H952 | 4 institutional holders
Watch
Quarters
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Q1 2022
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile